Literature DB >> 20132178

Toxic activity of the CdtB component of Haemophilus ducreyi cytolethal distending toxin expressed from an adenovirus 5 vector.

Catharina Wising1, Maria Magnusson, Karin Ahlman, Leif Lindholm, Teresa Lagergård.   

Abstract

The Haemophilus ducreyi cytolethal distending toxin (HdCDT) catalytic subunit CdtB has DNase-like activity and mediates DNA damage after its delivery into target cells. We constructed a replication-deficient adenovirus type 5 (Ad5) vector expressing CdtB and investigated the toxic properties of this vector on HeLa cells. Ad5CdtB caused loss of cell viability, morphologic changes, and cell cycle arrest, findings similar to HdCDT intoxication. This confirmed that CdtB is responsible for the toxicity of the holotoxin when expressed in cells following transduction by an adenoviral vector, and indicated a possible potential of this novel strategy in studies of activity of intracellular products and in gene therapy of cancer.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20132178     DOI: 10.1111/j.1600-0463.2009.02573.x

Source DB:  PubMed          Journal:  APMIS        ISSN: 0903-4641            Impact factor:   3.205


  3 in total

1.  Cellular interactions of the cytolethal distending toxins from Escherichia coli and Haemophilus ducreyi.

Authors:  Amandeep Gargi; Batcha Tamilselvam; Brendan Powers; Michael G Prouty; Tommie Lincecum; Aria Eshraghi; Francisco J Maldonado-Arocho; Brenda A Wilson; Kenneth A Bradley; Steven R Blanke
Journal:  J Biol Chem       Date:  2013-01-10       Impact factor: 5.157

2.  Functional Study of Haemophilus ducreyi Cytolethal Distending Toxin Subunit B.

Authors:  Benoît J Pons; Nicolas Loiseau; Saleha Hashim; Soraya Tadrist; Gladys Mirey; Julien Vignard
Journal:  Toxins (Basel)       Date:  2020-08-19       Impact factor: 4.546

3.  A new functional site W115 in CdtA is critical for Aggregatibacter actinomycetemcomitans cytolethal distending toxin.

Authors:  Lu Li; Cheng Ding; Jun-lan Duan; Mi-fang Yang; Ying Sun; Xiao-qian Wang; Yan Xu
Journal:  PLoS One       Date:  2013-06-03       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.